node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ATP2C2 | BPIFB3 | ENSP00000262429 | ENSP00000364643 | ATPase, Ca++ transporting, type 2C, member 2; This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium (By similarity) | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | 0.575 |
BPIFA1 | BPIFB3 | ENSP00000346251 | ENSP00000364643 | BPI fold containing family A, member 1; May be involved in the airway inflammatory response after exposure to irritants. May be associated with tumor progression. May play a role in innate immune responses of the upper airways | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | 0.408 |
BPIFA2 | BPIFA3 | ENSP00000253362 | ENSP00000364603 | BPI fold containing family A, member 2 | BPI fold containing family A, member 3 | 0.724 |
BPIFA2 | BPIFB1 | ENSP00000253362 | ENSP00000253354 | BPI fold containing family A, member 2 | BPI fold containing family B, member 1 | 0.814 |
BPIFA2 | BPIFB3 | ENSP00000253362 | ENSP00000364643 | BPI fold containing family A, member 2 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | 0.721 |
BPIFA3 | BPIFA2 | ENSP00000364603 | ENSP00000253362 | BPI fold containing family A, member 3 | BPI fold containing family A, member 2 | 0.724 |
BPIFA3 | BPIFB3 | ENSP00000364603 | ENSP00000364643 | BPI fold containing family A, member 3 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | 0.594 |
BPIFB1 | BPIFA2 | ENSP00000253354 | ENSP00000253362 | BPI fold containing family B, member 1 | BPI fold containing family A, member 2 | 0.814 |
BPIFB1 | BPIFB3 | ENSP00000253354 | ENSP00000364643 | BPI fold containing family B, member 1 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | 0.864 |
BPIFB1 | SAMD4B | ENSP00000253354 | ENSP00000317224 | BPI fold containing family B, member 1 | sterile alpha motif domain containing 4B; Has transcriptional repressor activity. Overexpression inhibits the transcriptional activities of AP-1, p53/TP53 and CDKN1A | 0.748 |
BPIFB3 | ATP2C2 | ENSP00000364643 | ENSP00000262429 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | ATPase, Ca++ transporting, type 2C, member 2; This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the transport of calcium (By similarity) | 0.575 |
BPIFB3 | BPIFA1 | ENSP00000364643 | ENSP00000346251 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | BPI fold containing family A, member 1; May be involved in the airway inflammatory response after exposure to irritants. May be associated with tumor progression. May play a role in innate immune responses of the upper airways | 0.408 |
BPIFB3 | BPIFA2 | ENSP00000364643 | ENSP00000253362 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | BPI fold containing family A, member 2 | 0.721 |
BPIFB3 | BPIFA3 | ENSP00000364643 | ENSP00000364603 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | BPI fold containing family A, member 3 | 0.594 |
BPIFB3 | BPIFB1 | ENSP00000364643 | ENSP00000253354 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | BPI fold containing family B, member 1 | 0.864 |
BPIFB3 | C19orf45 | ENSP00000364643 | ENSP00000355241 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | chromosome 19 open reading frame 45 | 0.632 |
BPIFB3 | CHRNA2 | ENSP00000364643 | ENSP00000385026 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | cholinergic receptor, nicotinic, alpha 2 (neuronal); After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane | 0.456 |
BPIFB3 | MAGEB10 | ENSP00000364643 | ENSP00000368304 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | melanoma antigen family B, 10 | 0.412 |
BPIFB3 | OR5I1 | ENSP00000364643 | ENSP00000301532 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | olfactory receptor, family 5, subfamily I, member 1; Odorant receptor (Potential) | 0.520 |
BPIFB3 | SAMD4B | ENSP00000364643 | ENSP00000317224 | BPI fold containing family B, member 3; May have the capacity to recognize and bind specific classes of odorants. May act as a carrier molecule, transporting odorants across the mucus layer to access receptor sites. May serve as a primary defense mechanism by recognizing and removing potentially harmful odorants or pathogenic microorganisms from the mucosa or clearing excess odorant from mucus to enable new odorant stimuli to be received (By similarity) | sterile alpha motif domain containing 4B; Has transcriptional repressor activity. Overexpression inhibits the transcriptional activities of AP-1, p53/TP53 and CDKN1A | 0.504 |